Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Robert R Peters"'
Publikováno v:
Veterinary Research
Veterinary Research, BioMed Central, 2004, 35 (5), pp.597-608. ⟨10.1051/vetres:2004035⟩
Veterinary Research, BioMed Central, 2004, 35 (5), pp.597-608. ⟨10.1051/vetres:2004035⟩
International audience; To characterize further the chemical and biological properties of bovine soluble (bos) CD14, a panel of ten murine monoclonal antibodies (mAb) reactive with recombinant (r) bosCD14 were produced. A sandwich ELISA, using murine
Publikováno v:
Veterinary Research
Veterinary Research, BioMed Central, 2007, 38 (6), pp.809-818. ⟨10.1051/vetres:2007033⟩
Veterinary Research, BioMed Central, 2007, 38 (6), pp.809-818. ⟨10.1051/vetres:2007033⟩
International audience; After intramammary infection, polymorphonuclear neutrophil leukocytes (PMN) are the first cells recruited into the mammary gland. Rapid recruitment of and bacterial phagocytosis and killing by PMN are the most effective defens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15f8d960e62dfe9708d1be35c0fce21
https://hal.archives-ouvertes.fr/hal-00902881/document
https://hal.archives-ouvertes.fr/hal-00902881/document
Publikováno v:
Veterinary Research
Veterinary Research, BioMed Central, 2007, 38 (1), pp.95-108. ⟨10.1051/vetres:2006052⟩
Veterinary Research, BioMed Central, 2007, 38 (1), pp.95-108. ⟨10.1051/vetres:2006052⟩
International audience; CD14, the leukocyte co-receptor for lipopolysaccharide (LPS), is important in the response of bovine polymorphonuclear neutrophil leukocytes (PMN) to Gram-negative bacteria. In other species, the expression of CD14 on the surf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3030029895d648f8ad5f84e9d3fc51a4
https://hal.archives-ouvertes.fr/hal-00902844/document
https://hal.archives-ouvertes.fr/hal-00902844/document
Autor:
Robert R. Peters, H. Allen Tucker
Publikováno v:
Endocrinology. 103(1)
Serum PRL, GH, and progesterone were measured at 1300 h twice weekly in heifers exposed to natural length or 16-h light (16L)-8-h dark (8D) during Nov. 11 to March 9 (n = 20) and April 30 to Aug. 13 (n = 18). Heifers exposed to 16L–8D received fluo
Autor:
Robert R. Peters
Publikováno v:
Journal - American Water Works Association. 70:1-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lessard S; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA. samuel.lessard@sanofi.com.; Precision Medicine and Computational Biology, Sanofi, Cambridge, MA, 02141, USA. samuel.lessard@sanofi.com., Rimmelé P; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Ling H; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Moran K; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Vieira B; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Lin YD; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Rajani GM; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Hong V; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Reik A; Sangamo Therapeutics, Richmond, CA, 94804, USA., Boismenu R; Sangamo Therapeutics, Richmond, CA, 94804, USA., Hsu B; Sangamo Therapeutics, Richmond, CA, 94804, USA., Chen M; Sangamo Therapeutics, Richmond, CA, 94804, USA., Cockroft BM; Sangamo Therapeutics, Richmond, CA, 94804, USA., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes/National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, National Institutes of Health (NIH), Bethesda, MD, USA., Tisdale J; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes/National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, National Institutes of Health (NIH), Bethesda, MD, USA., Alavi A; Henry Ford Cancer Institute, Detroit, MI, USA., Krishnamurti L; Emory University, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Abedi M; University of California-Davis Medical Center, Sacramento, CA, USA., Galeon I; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Reiner D; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Wang L; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Ramezi A; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Rendo P; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Walters MC; University of California San Francisco Benioff Children's Hospital, Oakland, CA, USA., Levasseur D; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Peters R; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Harris T; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA., Hicks A; Rare Blood Disorders, Sanofi, Waltham, MA, 02451, USA.; Immunology and Inflammation, Sanofi, Cambridge, MA, 02141, USA.
Publikováno v:
Scientific reports [Sci Rep] 2024 Oct 16; Vol. 14 (1), pp. 24298. Date of Electronic Publication: 2024 Oct 16.
Autor:
Schmidt J; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Yakac A; Department of Urology, University Hospital Carl Gustav Carus, Dresden, Germany., Peters R; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Friedersdorff F; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kernig K; Department of Urology, University of Rostock, Rostock, Germany., Kienel A; Department of Urology and Pediatric Urology, University Hospital Erlangen, Erlangen, Germany., Winterhagen FI; Department of Urology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany., Köpp F; Department of Urology, Jena University Hospital, Jena, Germany., Foller S; Department of Urology, Jena University Hospital, Jena, Germany., DiQuilio F; Department of Urology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany., Weigand K; Department of Urology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany., Flegar L; Department of Urology, Philipps-University Marburg, Marburg, Germany., Reimold P; Department of Urology, Philipps-University Marburg, Marburg, Germany., Stöckle M; Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany., Putz J; Department of Urology, University Hospital Carl Gustav Carus, Dresden, Germany., Zeuschner P; Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2024 Jul 29; Vol. 67, pp. 45-53. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).
Autor:
Liefeldt L; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany., Waiser J; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany., Bachmann F; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany., Budde K; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany., Friedersdorff F; Department of Urology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany., Halleck F; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany., Lachmann N; Centre for Tumor Medicine, H&I Laboratory, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany., Peters R; Department of Urology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany., Rudolph B; Department of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany., Ünlü S; Centre for Tumor Medicine, H&I Laboratory, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany., Wu K; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany., Glander P; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2024 Jul 23; Vol. 13 (15). Date of Electronic Publication: 2024 Jul 23.
Autor:
Spiesecke P; Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Radiology, Berlin, Germany., Schmidt J; Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Urology, Berlin, Germany., Peters R; Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Urology, Berlin, Germany., Fischer T; Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Radiology, Berlin, Germany., Hamm B; Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Radiology, Berlin, Germany., Lerchbaumer MH; Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Radiology, Berlin, Germany. Electronic address: markus.lerchbaumer@charite.de.
Publikováno v:
European journal of radiology [Eur J Radiol] 2024 Jul; Vol. 176, pp. 111513. Date of Electronic Publication: 2024 May 18.